Drug Firm Gilead’s Genvoya drug has been approved for for patients aged 12 and older and for adult patients whose HIV had been suppressed by other treatments.
Strides Arcolab Inks Deal With Gilead Sciences for HIV Drug
Pharma major Strides Arcolab has entered into a licensing agreement with US-based Gilead Sciences to manufacture and distribute latter's low-cost HIV drug.
Pharma major Strides Arcolab has entered into a licensing agreement with US-based Gilead Sciences to manufacture and distribute latter's low-cost HIV drug.
‘Genvoya, a new HIV drug has received a black box warning from the FDA as it causes severe liver problems, active acidosis and nausea. It must not be given with other antiretroviral products.’
It is administered once a day and may cause some side effects like nausea, severe liver problems and a dangerous buildup of lactic acid in the blood. Therefore FDA has given its black box warning for the drug. "While exceptional progress has been made in the field of HIV, there is still a need for new treatment options that may help improve the health of people as they grow older with the disease," said John C. Martin, Gilead CEO.
The drug has been approved for patients aged 12 and older who have never taken HIV medicines, and for adult patients whose HIV had been suppressed by other treatments for at least six months. Genvoya should not be given with other antiretroviral products and may have drug interactions with a number of other commonly used medications.
Doctors Without Borders Urge South Africa to Allow Generic Version of HIV Drugs
AbbVie, a drug firm patents prevent the use of generic versions of HIV drugs in South Africa and has refused to provide voluntary licenses to other companies.
AbbVie, a drug firm patents prevent the use of generic versions of HIV drugs in South Africa and has refused to provide voluntary licenses to other companies.
Genetic Differences May Lead to Failure of Anti-HIV Drug Tenofovir
Before prescribing tenofovir to a patient, a doctor could order genetic testing and know in advance if it works, and prescribe a different drug if it won't.
Before prescribing tenofovir to a patient, a doctor could order genetic testing and know in advance if it works, and prescribe a different drug if it won't.
Philippine Department of Health to Purchase Over $4 Million Worth of HIV Drugs
In February 2015, 646 new cases were reported in the Philippines, the biggest number reported in a month in the history of HIV in the country.
In February 2015, 646 new cases were reported in the Philippines, the biggest number reported in a month in the history of HIV in the country.
